Fundz

Gene Centric Therapeutics, Inc. reported raising $1.2 Million in an initial SEC Form D filing, from an offering of $1.2 Million

PRIVATEJan 13, 2021

Amount Raised

$1.2 Million

$1.2 Million sold, per SEC Form D (first sale Jan 13, 2021)

Round Type

Venture

DurhamBiotechnology

Quick answer

GeneCentric Therapeutics raised $1.2 Million in a funding round, dated January 13, 2021. GeneCentric Therapeutics is based in Durham, North Carolina, United States.

How much did GeneCentric Therapeutics raise?
GeneCentric Therapeutics raised $1.2 Million in a funding round on January 13, 2021.
What does GeneCentric Therapeutics do?
GeneCentric is a precision oncology company transforming cancer diagnostics and genomic profiling through the power of gene expression.
Where is GeneCentric Therapeutics based and how big is it?
GeneCentric Therapeutics is based in Durham, North Carolina, United States. Fundz records about 12 employees.
Who are the decision-makers at GeneCentric Therapeutics?
Fundz holds 1 contact at GeneCentric Therapeutics, including the Executive Officer, Director. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as GeneCentric Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • JUVA LIFE INC./Canada raised $208K (Pre-Seed) on February 26, 2021.
  • Lifeward raised $40M on February 26, 2021.
  • Forum Markets Incorporated raised $12M on February 26, 2021.
  • Artiva Biotherapeutics raised $120M (Series B) on February 26, 2021.
  • Artax Biopharma raised $2.2M (Seed) on February 26, 2021.
  • GeoVax Labs raised $495K on February 25, 2021.

Who to call at GeneCentric Therapeutics, and when

A new round usually means GeneCentric Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day GeneCentric Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at GeneCentric Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at GeneCentric Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

GeneCentric Therapeutics

Location

100 CAPITOLA DRIVE

Durham, North Carolina, United States

About

GeneCentric is a precision oncology company transforming cancer diagnostics and genomic profiling through the power of gene expression. With a foundation built on over a decade of research into gene expression, including the PurIST® test (commercially available through Tempus), GeneCentric has pioneered ExpressCT™, a proprietary technology that enables gene expression inference directly from circulating tumor DNA (ctDNA). This innovation is embodied in the GenomicsNext™ platform, a multimodal liquid biopsy solution that simultaneously detects DNA alterations and inferred gene expression from a single blood sample.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment GeneCentric Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsMyla L., Executive Officer, Director hidden hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for GeneCentric Therapeutics's next move

See what Strategic adds

GeneCentric Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.